Manutara Ventures

Manutara Ventures is a Santiago-based fund specializing in early-stage technology companies with high global scalability potential. Check sizes of $250k to $1M place the firm in the seed range, suitable for participating in or anchoring small priced rounds. Healthcare exposure spans AI/ML in healthcare, health IT, and digital health, with explicit AI thematic positioning. The input record cites Xmartic as a portfolio example.

The firm’s natural fit is with Chilean and broader LatAm founders building technology products with credible cross-border ambitions. The global scalability emphasis means Manutara is more interested in companies whose product can be sold internationally from day one, not in companies whose moat depends on Chilean local market knowledge. For healthcare founders specifically, this means AI-enabled clinical software, health IT platforms with multi-country deployments, and digital health products with US or European TAM exposure. Founders building purely local Chilean care delivery models are not the natural target.

Geographically, Chile is a stable jurisdiction with strong technical talent, transparent regulatory environment, and connectivity to the Pacific Alliance. Manutara’s local network can help founders with regional follow-on capital, US co-investor introductions, and the operational realities of running a globally scalable company from a Chilean base. For founders without Chilean or LatAm ties, the strategic logic is thinner.

The right entry path is a warm intro from a portfolio founder or another regional VC. The firm reads partner-led decks and responds to clear global-scalability theses. The pitch should lead with the international TAM, the technical moat, and a credible plan for cross-border GTM. Healthcare-specific pitches should explain why the product is differentiated in international markets, not just locally.

Caveats. Chilean fund structures interact with cross-border venture dynamics in idiosyncratic ways; engage regional corporate counsel from day one. The firm’s healthcare-specific portfolio depth is not as visible publicly as its broader technology portfolio; reference calls with portfolio founders, including Xmartic, are advisable. The check range is narrow; for founders raising larger seeds, Manutara should be a participant alongside a real lead. For LatAm founders building globally scalable AI-enabled health technology with Chilean operational anchors, Manutara is a credible early partner; for founders without regional ties, the fit is weaker.